tradingkey.logo

Cardiol Therapeutics Inc <CRDL.TO> expected to post a loss of 13 cents a share - Earnings Preview

ReutersApr 18, 2025 8:02 PM
  • Cardiol Therapeutics Inc CRDL.TO is expected to show no change in quarterly revenue when it reports results on April 21 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Cardiol Therapeutics Inc is for a loss of 13 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had risen by about 8.8% in the last three months. ​

  • Wall Street's median 12-month price target for Cardiol Therapeutics Inc is $9.00​, above​ its last closing price of $1.01. ​​​

This summary was machine generated April 18 at 20:02 GMT. All figures in Canadian dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI